Pharmacies typically put an expiration date of one year ( or less , such as in Pennsylvania) on the prescription label
Orskov, C., Bersani, M., Johnsen, A
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
Noom expands its GLP-1 range with 'microdose' package Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price
The available evidence from other trials is summarized in the accompanying de novo meta-analysis7 but the kidney outcomes definitions have varied among trials (Supplemental Table S1)
According to the American Society of Anesthesiologists consensus guidelines, if the patient has reported gastrointestinal side effects of nausea or vomiting due to a GLP-1 receptor agonist, they must be considered at increased risk for complications requiring full-stomach precautions for anesthesia